Lifecore Biomedical, Inc. (LFCR) 追踪市盈率为负值 -4.6, 表示公司目前在过去十二个月 (TTM) 基础上处于亏损状态。 追踪盈利收益率为 -21.68%.
本页证实的标准:
SharesGrow 综合评分： 40/100 其中 2/7 项标准通过。
| Year | P/E (TTM) | PEG 比率 | P/B 比率 | P/S 比率 | 股息收益率 |
|---|---|---|---|---|---|
| 2016 | -26.9 | 0.14 | 1.49 | 0.58 | - |
| 2017 | 36.4 | -0.19 | 1.70 | 0.72 | - |
| 2018 | 15.7 | 0.12 | 1.55 | 0.75 | - |
| 2019 | 132.6 | -1.45 | 1.04 | 0.50 | - |
| 2020 | -8.3 | 0.00 | 1.37 | 1.97 | - |
| 2021 | -10.6 | 0.73 | 1.68 | 3.38 | - |
| 2022 | -2.5 | -0.01 | 3.31 | 2.61 | - |
| 2023 | -2.4 | 0.15 | -56.23 | 2.30 | - |
| 2024 | 14.3 | -0.13 | 15.14 | 1.34 | - |
| 2025 | -6.0 | 0.01 | 175.14 | 1.82 | - |
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2016 | $-0.43 | $541.1M | $-11.64M | -2.2% |
| 2017 | $0.38 | $532.26M | $10.59M | 2% |
| 2018 | $0.89 | $524.23M | $24.83M | 4.7% |
| 2019 | $0.07 | $557.56M | $2.12M | 0.4% |
| 2020 | $-1.31 | $590.37M | $-38.19M | -6.5% |
| 2021 | $-1.12 | $544.16M | $-32.67M | -6% |
| 2022 | $-1.56 | $185.79M | $-46.08M | -24.8% |
| 2023 | $-3.41 | $103.27M | $-102.19M | -99% |
| 2024 | $0.33 | $128.26M | $12.01M | 9.4% |
| 2025 | $-1.27 | $128.87M | $-38.72M | -30% |
| Year | EPS（平均） | EPS 范围 | 营收（平均） | 营收范围 | 分析师人数 |
|---|---|---|---|---|---|
| 2026 | $-0.48 | $-0.50 – $-0.46 | $75.12M | $73.08M – $77.62M | 2 |
| 2027 | $-0.89 | $-0.91 – $-0.85 | $122.68M | $119.95M – $124.85M | 2 |
| 2028 | $-0.87 | $-0.89 – $-0.85 | $131.97M | $129.75M – $134.41M | 1 |
| 2029 | $-0.91 | $-0.93 – $-0.89 | $152.62M | $150.05M – $155.44M | 1 |
